{"filings":[{"id":2080556,"accession_number":"0001193125-26-335356","cik":1076930,"company_name":"NOVANTA INC","ticker":"NOVT","form_type":"8-K","filed_at":"2026-08-05T20:50:16+00:00","items":["2.02","9.01"],"status":"ready","headline":"Novanta Q2 2026 revenue up 10% to $266M; adjusted EPS up 17% to $0.89","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["GAAP revenue $265.8M, up 10% YoY from $241.0M; net income $12.5M vs $4.5M.","GAAP diluted EPS $0.30 vs $0.12; adjusted diluted EPS $0.89, up 17% from $0.76.","Adjusted EBITDA $60.7M, up 16% YoY; adjusted operating income $47.5M vs $40.7M.","Second quarter ended July 3, 2026; results reported on August 5, 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":5751671008.7092905,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":1868559,"accession_number":"0001193125-26-316947","cik":1076930,"company_name":"NOVANTA INC","ticker":"NOVT","form_type":"8-K","filed_at":"2026-07-27T12:15:15+00:00","items":["2.01","1.01","2.03","7.01","9.01"],"status":"ready","headline":"Novanta completes $1.2B acquisition of Riverpoint Medical; expects $0.18-$0.25 adjusted EPS accretion in 2027","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Acquired Riverpoint Medical for ~$1.2B cash at closing; additional $250M milestone payment due by Jan 8, 2027.","Funded with $616M in borrowings under credit facilities; total consolidated debt now $854.7M.","Deal expected to double recurring medical consumables revenue to ~$300M and push medical end-market to 60% of total revenue.","Expects $0.18-$0.25 adjusted EPS accretion in 2027, high single-digit ROIC by year three, and immediate accretion to margins.","Riverpoint is a category leader in minimally invasive surgical consumables for sports medicine, trauma, and cardiovascular applications."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":5751671008.7092905,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":947566,"accession_number":"0001193125-26-263979","cik":1076930,"company_name":"NOVANTA INC","ticker":"NOVT","form_type":"8-K","filed_at":"2026-06-09T21:00:16+00:00","items":["1.01","3.02","8.01","9.01"],"status":"ready","headline":"Novanta raises $300M via private placement of 2.1M shares at $140 each","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Sold 2,142,857 common shares at $140.00 each for gross proceeds of ~$300M.","Closing expected on June 11, 2026, subject to customary conditions.","Shares issued under Section 4(a)(2) exemption; resale registration rights agreement filed.","Proceeds intended for general corporate purposes; no specific use disclosed.","J.P. Morgan, William Blair, CJS Securities, PNC Capital Markets acted as placement agents."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":5751671008.7092905,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":926958,"accession_number":"0001193125-26-262867","cik":1076930,"company_name":"NOVANTA INC","ticker":"NOVT","form_type":"8-K","filed_at":"2026-06-09T10:02:06+00:00","items":["1.01","7.01","9.01"],"status":"ready","headline":"Novanta acquires Riverpoint Medical for $1.2B cash plus $250M milestone; recurring medical consumables to double","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Upfront cash consideration of $1.2B; milestone payment of $250M due Q1 2027.","Expected close Q3 2026, subject to HSR clearance and customary conditions.","Financing via cash on hand, existing credit facility, and $300M equity raise.","Riverpoint estimated 2027 Adjusted EBITDA ~$80M with synergies; upfront price ~19x 2026 EBITDA.","Medical consumables revenue to double to ~$300M; medical end-market to 60% of total revenue."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":5751671008.7092905,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":748078,"accession_number":"0001193125-26-248524","cik":1076930,"company_name":"NOVANTA INC","ticker":"NOVT","form_type":"8-K","filed_at":"2026-05-29T20:45:15+00:00","items":["5.07"],"status":"ready","headline":"Novanta shareholders elect all nine directors and approve executive compensation at annual meeting","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["All nine director nominees elected; votes for ranged from 30.98M to 31.74M.","Advisory say-on-pay approved with 31.07M FOR (97.8% of votes cast).","Deloitte & Touche ratified as auditor with 33.35M FOR (99.98%).","Approximately 93.7% of outstanding shares were represented at the meeting."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.15,"market_cap_usd":5751671008.7092905,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":472077,"accession_number":"0001193125-26-227053","cik":1076930,"company_name":"NOVANTA INC","ticker":"NOVT","form_type":"8-K","filed_at":"2026-05-15T20:45:17+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"Novanta enters $200M delayed draw term loan facility maturing 2030","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Second Amendment to Credit Agreement establishes $200M delayed draw term loan commitments.","Loans available for up to six months after May 15, 2026; mature June 27, 2030.","Interest: Base Rate plus 0.00%-0.75% or SOFR/SONIA/EURIBOR plus 1.00%-1.75%, based on leverage.","Quarterly amortization starts Sep 25, 2026: 0.625% of principal early, 1.25% later.","Commitment fee payable on undrawn commitments; incremental capacity reset."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":5751671008.7092905,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":14483,"accession_number":"0001193125-26-216984","cik":1076930,"company_name":"NOVANTA INC","ticker":"NOVT","form_type":"8-K","filed_at":"2026-05-11T20:45:18+00:00","items":["2.02","9.01"],"status":"ready","headline":"Novanta Q1 revenue up 10% to $258M, adjusted EPS $0.81, net income $21M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["GAAP revenue $257.7M (+10% YoY); GAAP net income $21.1M (flat).","GAAP diluted EPS $0.51 (vs $0.59 YoY); adjusted diluted EPS $0.81 (+9%).","Adjusted EBITDA $57.1M (+14% YoY); adjusted operating income $43.2M.","No forward guidance or segment details provided in the press release."],"consensus_eps_estimate":0.7922,"consensus_eps_actual":0.51,"consensus_revenue_estimate":null,"consensus_revenue_actual":257707000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl+finnhub","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":5751671008.7092905,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":101045,"accession_number":"0001193125-26-064191","cik":1076930,"company_name":"NOVANTA INC","ticker":"NOVT","form_type":"8-K","filed_at":"2026-02-23T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Novanta Q4 revenue $258M (+9% YoY), adjusted EPS $0.91 (+20% YoY)","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["GAAP revenue $258.3M in Q4 2025, up 9% YoY; GAAP diluted EPS $0.45.","Adjusted diluted EPS $0.91 in Q4 2025, up 20% YoY; Adjusted EBITDA $60.7M (+17%).","Full year 2025 GAAP revenue $980.6M (+3% YoY); GAAP diluted EPS $1.47.","Full year 2025 adjusted diluted EPS $3.29; Adjusted EBITDA $221M."],"consensus_eps_estimate":0.8976,"consensus_eps_actual":1.47,"consensus_revenue_estimate":null,"consensus_revenue_actual":980600000.0,"consensus_period":"2025-FY","consensus_source":"xbrl+finnhub","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":5751671008.7092905,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":117391,"accession_number":"0001193125-25-303940","cik":1076930,"company_name":"NOVANTA INC","ticker":"NOVT","form_type":"8-K","filed_at":"2025-12-01T23:59:59+00:00","items":["7.01"],"status":"ready","headline":"Novanta appoints Alexander Manganiello as General Counsel and Corporate Secretary","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Appointed Alexander Manganiello as General Counsel and Corporate Secretary effective December 1, 2025.","Prior role: VP, Deputy General Counsel at Vertex Pharmaceuticals (2019-2025).","Previously held senior legal roles at Pfizer Inc. (2004-2019) and practiced at Ropes & Gray.","Holds A.B. Biology from Harvard University and J.D. from Suffolk Law School."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":5751671008.7092905,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":117390,"accession_number":"0001193125-25-280353","cik":1076930,"company_name":"NOVANTA INC","ticker":"NOVT","form_type":"8-K","filed_at":"2025-11-13T23:59:59+00:00","items":["7.01"],"status":"ready","headline":"Novanta revises Q4 and FY 2025 adjusted EPS guidance lower after equity issuance","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Q4 2025 non-GAAP adjusted diluted EPS now $0.84-$0.91 (prior $0.87-$0.93).","FY 2025 non-GAAP adjusted diluted EPS now $3.21-$3.28 (prior $3.24-$3.30).","GAAP revenue guidance unchanged: Q4 $253M-$257M, FY $975M-$979M.","Q4 diluted share count impact estimated at 2.5M-2.6M additional shares; FY impact 0.6M-0.7M.","FY 2026 diluted share count impact estimated between 4.7M and 5.9M shares."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":5751671008.7092905,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":117389,"accession_number":"0001193125-25-277939","cik":1076930,"company_name":"NOVANTA INC","ticker":"NOVT","form_type":"8-K","filed_at":"2025-11-12T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"Novanta closes $632.5M tangible equity units offering; amends credit agreement","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Issued 12,650,000 Units at $50.00 each, including full over-allotment exercise.","Each Unit includes a prepaid stock purchase contract and a senior amortizing note yielding 6.50%.","Net proceeds to strengthen balance sheet; ~$317M of revolving credit to be repaid.","Credit amendment raises max leverage ratio to 3.75:1 (4.25:1 step-up for acquisitions).","Amendment conditioned on tangible equity unit issuance by Dec 31, 2025; condition met."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":5751671008.7092905,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":117388,"accession_number":"0001193125-25-262744","cik":1076930,"company_name":"NOVANTA INC","ticker":"NOVT","form_type":"8-K","filed_at":"2025-11-03T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Novanta Q3 2025 revenue up 1.4% to $247.8M; GAAP EPS drops to $0.30 from $0.53","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["GAAP revenue $247.8M (+1.4% YoY); GAAP net income $10.7M vs $19.2M in Q3 2024.","GAAP diluted EPS $0.30 vs $0.53; adjusted diluted EPS $0.87 vs $0.85.","Adjusted EBITDA $58.1M vs $57.0M; adjusted operating income $47.4M vs $46.8M.","GAAP operating income $21.8M vs $32.6M YoY, a decline of 33%."],"consensus_eps_estimate":0.833,"consensus_eps_actual":1.01,"consensus_revenue_estimate":null,"consensus_revenue_actual":722251000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl+finnhub","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":5751671008.7092905,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":133809,"accession_number":"0001193125-25-207465","cik":1076930,"company_name":"NOVANTA INC","ticker":"NOVT","form_type":"8-K","filed_at":"2025-09-18T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Novanta director Barbara Hulit resigns from board, effective Nov 1, 2025","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Barbara Hulit resigned from Novanta's Board, effective November 1, 2025.","She also resigned from the Audit Committee and ESG Committee.","Resignation was not due to any disagreement with the company."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":5751671008.7092905,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":133808,"accession_number":"0001193125-25-206858","cik":1076930,"company_name":"NOVANTA INC","ticker":"NOVT","form_type":"8-K","filed_at":"2025-09-18T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Novanta board authorizes additional $200M share repurchase; total capacity $231M","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Board approved $200M additional common share repurchase authorization on Sept 17, 2025.","$31M remained under 2020 authorization; combined capacity now $231M as of Sept 18, 2025.","Repurchases may occur via open market, private deals, or accelerated agreements subject to market conditions.","No expiration date; program can be suspended or discontinued at any time at Company's discretion.","Company is not obligated to repurchase any specific amount of shares."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":5751671008.7092905,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":133807,"accession_number":"0000950170-25-102416","cik":1076930,"company_name":"NOVANTA INC","ticker":"NOVT","form_type":"8-K","filed_at":"2025-08-05T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Novanta Q2 2025 GAAP EPS falls 68% to $0.12; Adj. EPS rises to $0.76 on 2% revenue growth","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["GAAP revenue $241.0M (+2% YoY); GAAP net income $4.5M vs $13.8M; GAAP diluted EPS $0.12 vs $0.38.","Adjusted diluted EPS $0.76 vs $0.73; Adjusted EBITDA $52.2M vs $51.1M; adjusted operating income $40.7M.","GAAP operating income $14.9M vs $25.7M YoY, impacted by non-recurring charges and amortization.","Company updated its full year 2025 financial guidance (specific ranges not provided in the release excerpt)."],"consensus_eps_estimate":0.748,"consensus_eps_actual":0.71,"consensus_revenue_estimate":null,"consensus_revenue_actual":474415000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl+finnhub","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":5751671008.7092905,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":133806,"accession_number":"0000950170-25-095309","cik":1076930,"company_name":"NOVANTA INC","ticker":"NOVT","form_type":"8-K","filed_at":"2025-07-11T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Novanta General Counsel & Corporate Secretary Michele D. Welsh to depart July 18, 2025","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Michele D. Welsh will no longer serve as General Counsel and Corporate Secretary effective July 18, 2025, or earlier if mutually agreed.","No successor has been announced for the role of General Counsel and Corporate Secretary.","Ms. Welsh's severance entitlement under her employment agreement remains unchanged; no other departure terms disclosed."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":5751671008.7092905,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":133805,"accession_number":"0000950170-25-093046","cik":1076930,"company_name":"NOVANTA INC","ticker":"NOVT","form_type":"8-K","filed_at":"2025-07-02T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"Novanta enters $1.0B credit facility maturing 2030; replaces $392.4M existing debt","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Facility includes €65.31M euro term loan, $75M US term loan, $850M revolver; maturity June 2030.","Replaces existing credit agreement that had $392.4M outstanding as of March 28, 2025.","Accordion feature allows up to $350M additional commitments subject to conditions.","Financial covenants: min fixed charge coverage 1.25:1.00, max leverage 3.50:1.00 (4.00:1.00 after large acquisitions)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":5751671008.7092905,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":150540,"accession_number":"0000950170-25-083785","cik":1076930,"company_name":"NOVANTA INC","ticker":"NOVT","form_type":"8-K","filed_at":"2025-06-09T23:59:59+00:00","items":["2.05"],"status":"ready","headline":"Novanta announces restructuring plan with $20M-$25M pre-tax charges","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Pre-tax charges estimated at $20M-$25M from employee-related costs, manufacturing moves, contract terminations, and asset write-offs.","Plan aims to regionalize manufacturing, close certain sites, and streamline management; starts June 2025, completion within 18 months.","Annualized savings of approximately $20M expected after plan is substantially completed."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":5751671008.7092905,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":150539,"accession_number":"0000950170-25-080208","cik":1076930,"company_name":"NOVANTA INC","ticker":"NOVT","form_type":"8-K","filed_at":"2025-06-02T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Novanta holds annual meeting; all director nominees elected, advisory votes approved","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["All nine director nominees elected with substantial support (each received >31M votes for).","Advisory vote on executive compensation passed with 31.0M for vs 928k against.","Shareholders recommended a 1-year frequency for future advisory votes on exec comp; board adopted annual vote.","Deloitte & Touche ratified as independent auditor with 33.9M votes for, 36k withheld.","Approximately 94.3% of outstanding shares were represented at the meeting."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":5751671008.7092905,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":150538,"accession_number":"0000950170-25-063976","cik":1076930,"company_name":"NOVANTA INC","ticker":"NOVT","form_type":"8-K","filed_at":"2025-05-06T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Novanta Q1 rev +1% to $233M; GAAP NI +45%; adj EPS flat $0.74","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["GAAP revenue $233.4M (+1% YoY); GAAP net income $21.2M (+45%); GAAP diluted EPS $0.59 vs $0.41.","Adjusted diluted EPS $0.74 (flat YoY); adjusted EBITDA $50M (+1%); operating cash flow $32M.","Company reaffirms full-year 2025 adjusted EBITDA guidance; no change to outlook."],"consensus_eps_estimate":null,"consensus_eps_actual":0.59,"consensus_revenue_estimate":null,"consensus_revenue_actual":233366000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":5751671008.7092905,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":169502,"accession_number":"0000950170-25-026854","cik":1076930,"company_name":"NOVANTA INC","ticker":"NOVT","form_type":"8-K","filed_at":"2025-02-25T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Novanta recasts segment reporting into Automation Enabling Technologies and Medical Solutions","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Two new segments replace prior three-segment structure (Precision Medicine & Manufacturing, Robotics & Automation, Medical Solutions).","Automation Enabling Technologies FY2024 revenue $490.6M, operating income $106.4M (up 10.5% YoY).","Medical Solutions FY2024 revenue $458.6M (up 19.9% YoY), operating income $57.5M (down 9.1% YoY).","Total FY2024 revenue $949.2M, operating income $110.6M; gross margin 44.4% vs 45.4% in FY2023.","Q4 2024 Medical Solutions operating income dropped to $7.0M from $15.8M a year earlier."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":5751671008.7092905,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":169501,"accession_number":"0000950170-25-026093","cik":1076930,"company_name":"NOVANTA INC","ticker":"NOVT","form_type":"8-K","filed_at":"2025-02-25T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Novanta Reports Q4 and Full Year 2024 Results: Revenue Up 13% in Q4, 8% for Full Year","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 2024 revenue increased 13% to $238M; GAAP diluted EPS $0.46, adjusted EPS $0.76.","Full year 2024 revenue rose 8% to $949M; GAAP diluted EPS $1.77, adjusted EPS $3.08.","Full year 2024 adjusted EBITDA grew 7% to $210M; operating cash flow up 32% to $159M.","Results released via press release on February 25, 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":1.77,"consensus_revenue_estimate":null,"consensus_revenue_actual":949245000.0,"consensus_period":"2024-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.9,"calibrated_materiality_score":0.9,"market_cap_usd":5751671008.7092905,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":186554,"accession_number":"0000950170-24-121078","cik":1076930,"company_name":"NOVANTA INC","ticker":"NOVT","form_type":"8-K","filed_at":"2024-11-05T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Novanta Q3 2024 revenue up 10% to $244M; GAAP EPS $0.53 vs $0.59 a year ago","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $244.4M, +10% YoY from $221.5M.","GAAP net income $19.2M ($0.53 diluted EPS) vs $21.2M ($0.59) in Q3 2023.","Adjusted diluted EPS $0.85 flat YoY.","Adjusted EBITDA $57.0M, +9% from $52.2M in prior-year period.","GAAP operating income $32.6M vs $30.3M a year ago."],"consensus_eps_estimate":null,"consensus_eps_actual":1.32,"consensus_revenue_estimate":null,"consensus_revenue_actual":711185000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":5751671008.7092905,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":203130,"accession_number":"0000950170-24-100196","cik":1076930,"company_name":"NOVANTA INC","ticker":"NOVT","form_type":"8-K","filed_at":"2024-08-23T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Novanta appoints John Burke as Chief Accounting Officer; Peter Chang departs after 13 years","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["John Burke, former VP Global Accounting, named CAO effective Aug 22, 2024, succeeding Peter Chang.","Peter Chang served 13 years as CAO; will advise CFO until Feb 28, 2025; departure not due to any disagreement.","Burke receives initial equity grant of $300,000 in RSUs vesting over 3 years, plus severance and change-in-control benefits.","Burke is a CPA with prior roles at MilliporeSigma and PricewaterhouseCoopers."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":5751671008.7092905,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":203129,"accession_number":"0000950170-24-091213","cik":1076930,"company_name":"NOVANTA INC","ticker":"NOVT","form_type":"8-K","filed_at":"2024-08-06T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Novanta Q2 2024 revenue up 2.8% to $236M, but GAAP EPS falls 34% to $0.38","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $235.9M (+2.8% YoY); GAAP net income $13.8M vs $20.9M in Q2 2023.","GAAP diluted EPS $0.38 vs $0.58; adjusted diluted EPS $0.73 vs $0.80.","Adjusted EBITDA $51.1M essentially flat vs $51.7M prior year.","Operating income $25.7M vs $32.2M YoY, reflecting lower margins."],"consensus_eps_estimate":null,"consensus_eps_actual":0.79,"consensus_revenue_estimate":null,"consensus_revenue_actual":466780000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":5751671008.7092905,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":203128,"accession_number":"0000950170-24-089941","cik":1076930,"company_name":"NOVANTA INC","ticker":"NOVT","form_type":"8-K","filed_at":"2024-08-02T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Novanta announces departure of CHRO Brian Young effective Nov 1, 2024","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Brian Young, Chief Human Resources Officer, to leave Novanta effective Nov 1, 2024 or earlier as agreed.","No changes to severance entitlements under his April 21, 2017 employment agreement.","No successor has been named as of the filing date."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":5751671008.7092905,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":203127,"accession_number":"0000950170-24-083196","cik":1076930,"company_name":"NOVANTA INC","ticker":"NOVT","form_type":"8-K","filed_at":"2024-07-12T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Novanta director Katherine Owen resigns; Mary Kay Ladone elected to board","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Katherine A. Owen resigned from board and Audit Committee on July 11, 2024, effective immediately; no disagreement cited.","Mary Katherine (Mary Kay) Ladone elected to board to fill vacancy, effective July 11, 2024.","Ladone will receive standard non-employee director compensation: $67,500 annual cash retainer and $200,000 in RSUs, prorated for 2024.","Ladone will enter into Novanta's standard indemnification agreement for directors and officers."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":5751671008.7092905,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":219428,"accession_number":"0000950170-24-056836","cik":1076930,"company_name":"NOVANTA INC","ticker":"NOVT","form_type":"8-K","filed_at":"2024-05-09T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Novanta shareholders approve all proposals at 2024 annual meeting","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["94.33% of outstanding shares (33.9M) were present or represented at the May 8, 2024 AGM.","All nine director nominees elected: votes for ranged from 32.5M to 33.0M; broker non-votes 829,290.","Advisory vote on executive compensation approved: 32.4M for, 625K against, 13K abstained.","Deloitte & Touche LLP ratified as auditor with 33.8M votes for and 40K withheld."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":5751671008.7092905,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":219427,"accession_number":"0000950170-24-053957","cik":1076930,"company_name":"NOVANTA INC","ticker":"NOVT","form_type":"8-K","filed_at":"2024-05-07T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Novanta Q1 2024 revenue up 5.4% to $231M; GAAP net income down to $14.7M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["GAAP revenue $230.9M vs $219.1M YoY; GAAP net income $14.7M vs $18.3M.","GAAP diluted EPS $0.41 vs $0.51; Adjusted diluted EPS flat at $0.74.","Adjusted EBITDA $49.7M vs $47.0M; Adjusted operating income $40.1M vs $36.9M.","No forward guidance provided in the release."],"consensus_eps_estimate":null,"consensus_eps_actual":0.41,"consensus_revenue_estimate":null,"consensus_revenue_actual":230916000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":5751671008.7092905,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":239262,"accession_number":"0000950170-24-032232","cik":1076930,"company_name":"NOVANTA INC","ticker":"NOVT","form_type":"8-K","filed_at":"2024-03-15T23:59:59+00:00","items":["4.01","9.01"],"status":"ready","headline":"Novanta replaces PwC with Deloitte as independent auditor after competitive process","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Board requested PwC's resignation effective March 14, 2024, engaging Deloitte as successor.","PwC's reports for FY 2022 and FY 2023 contained no adverse opinion or modification.","No disagreements or reportable events between Novanta and PwC in the relevant periods.","Change driven by compliance with the Business Corporations Act (New Brunswick)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":5751671008.7092905,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":239261,"accession_number":"0000950170-24-021670","cik":1076930,"company_name":"NOVANTA INC","ticker":"NOVT","form_type":"8-K","filed_at":"2024-02-28T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Novanta reports Q4 revenue $211.6M, FY 2023 GAAP EPS $2.02, adjusted EPS $3.02","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 2023 revenue $211.6M (down 3% YoY); GAAP diluted EPS $0.35 vs $0.42.","Full year 2023 revenue $881.7M, up 2.4% YoY; GAAP net income $72.9M vs $74.1M.","Full year adjusted diluted EPS $3.02, down from $3.07; adjusted EBITDA $196.2M vs $184.1M.","Q4 adjusted operating income $34.7M vs $37.3M YoY; adjusted EPS $0.63 vs $0.75."],"consensus_eps_estimate":null,"consensus_eps_actual":2.02,"consensus_revenue_estimate":null,"consensus_revenue_actual":881662000.0,"consensus_period":"2023-FY","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":5751671008.7092905,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":239260,"accession_number":"0000950170-24-000289","cik":1076930,"company_name":"NOVANTA INC","ticker":"NOVT","form_type":"8-K","filed_at":"2024-01-02T23:59:59+00:00","items":["2.03","7.01","9.01"],"status":"ready","headline":"Novanta completes acquisition of Motion Solutions; draws $198M under credit facility","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Acquired 100% of Motion Solutions capital stock for ~$192.2M using revolving credit facility draw of $198M.","Motion Solutions provides high-precision motion subsystems for medical and life sciences OEMs.","CEO Matthijs Glastra highlights growth in precision medicine applications at high-single-digit to low-double-digit rates.","Remaining $5.8M from draw used for general corporate purposes; facility matures December 2027."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":5751671008.7092905,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":256771,"accession_number":"0000950170-23-063728","cik":1076930,"company_name":"NOVANTA INC","ticker":"NOVT","form_type":"8-K","filed_at":"2023-11-14T23:59:59+00:00","items":["1.01","2.03","7.01","9.01"],"status":"ready","headline":"Novanta to acquire Motion Solutions for $189M cash; expected close Q1 2024","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Purchase price $189M in cash, financed with cash on hand and revolving credit facility.","Motion Solutions expected to generate ~$85M revenue in 2023; employs over 110 in Irvine, CA.","Acquisition expands Novanta's position in spatial biology, genomics, proteomics, medical robotics, and lab automation.","Closing subject to HSR antitrust waiting period, expected Q1 2024.","Conference call on Nov 14, 2023 at 5:00 p.m. ET to discuss the transaction."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":5751671008.7092905,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":256770,"accession_number":"0000950170-23-059776","cik":1076930,"company_name":"NOVANTA INC","ticker":"NOVT","form_type":"8-K","filed_at":"2023-11-07T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Novanta reports Q3 2023 GAAP revenue of $221.5M, adjusted EPS $0.85","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["GAAP revenue $221.5M vs $223.0M YoY; GAAP net income $21.2M vs $22.5M.","GAAP diluted EPS $0.59 vs $0.63; adjusted diluted EPS $0.85 vs $0.81.","Adjusted EBITDA $52.2M vs $49.4M, up 5.7% YoY.","GAAP operating income $30.3M; adjusted operating income $43.0M."],"consensus_eps_estimate":null,"consensus_eps_actual":1.68,"consensus_revenue_estimate":null,"consensus_revenue_actual":670093000.0,"consensus_period":"2023-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":5751671008.7092905,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":274127,"accession_number":"0000950170-23-039378","cik":1076930,"company_name":"NOVANTA INC","ticker":"NOVT","form_type":"8-K","filed_at":"2023-08-08T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Novanta Q2 revenue up 7% to $229.5M; GAAP EPS $0.58, adj. EPS $0.80","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["GAAP revenue $229.5M, +7% YoY from $215.4M; operating income $32.2M vs $23.3M.","Consolidated net income $20.9M, GAAP diluted EPS $0.58 vs $0.49 YoY.","Adjusted diluted EPS $0.80 vs $0.78; adjusted EBITDA $51.7M, +15% vs $45.0M.","Non-GAAP adjusted operating income $42.1M, compared to $36.7M in prior year."],"consensus_eps_estimate":null,"consensus_eps_actual":1.09,"consensus_revenue_estimate":null,"consensus_revenue_actual":448590000.0,"consensus_period":"2023-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":5751671008.7092905,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":291312,"accession_number":"0000950170-23-021295","cik":1076930,"company_name":"NOVANTA INC","ticker":"NOVT","form_type":"8-K","filed_at":"2023-05-11T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Novanta shareholders elect all eight director nominees and approve compensation and auditor at 2023 AGM","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["All eight director nominees elected: Lonny Carpenter, Matthijs Glastra, Barbara Hulit, Maxine Mauricio, Katherine Owen, Thomas Secor, Darlene Solomon, Frank Wilson.","Advisory vote on executive compensation passed with 31,773,157 votes for, 931,107 against, 16,777 abstained.","PricewaterhouseCoopers LLP ratified as independent auditor for 2024 with 33,292,275 votes for, 163,929 withheld."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"market_cap_usd":5751671008.7092905,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":291311,"accession_number":"0000950170-23-019155","cik":1076930,"company_name":"NOVANTA INC","ticker":"NOVT","form_type":"8-K","filed_at":"2023-05-09T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Novanta Q1 2023 revenue up 7% to $219M; GAAP EPS $0.51, adjusted EPS $0.74","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["GAAP revenue $219.1M (+7% YoY); GAAP net income $18.3M vs $18.8M YoY.","GAAP diluted EPS $0.51 vs $0.53 Q1 2022; adjusted diluted EPS $0.74 vs $0.73.","Adjusted EBITDA of $47.0M, up from $43.6M in Q1 2022.","Non-GAAP adjusted operating income $36.9M vs $33.5M year-over-year."],"consensus_eps_estimate":null,"consensus_eps_actual":0.51,"consensus_revenue_estimate":null,"consensus_revenue_actual":219126000.0,"consensus_period":"2023-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":5751671008.7092905,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":312103,"accession_number":"0000950170-23-007287","cik":1076930,"company_name":"NOVANTA INC","ticker":"NOVT","form_type":"8-K","filed_at":"2023-03-10T23:59:59+00:00","items":["7.01"],"status":"ready","headline":"Novanta discloses minimal SVB exposure: cash <$400k, 10% of credit facility","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["SVB is one of seven lenders under Novanta's $695M credit agreement, representing about 10% of total commitments.","Company's cash and cash equivalents held at SVB are less than $400,000.","Disclosure in response to media reports of SVB closure and FDIC appointment as receiver.","No material financial impact expected given minimal cash balance and diversified lender group."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":5751671008.7092905,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":312102,"accession_number":"0000950170-23-005344","cik":1076930,"company_name":"NOVANTA INC","ticker":"NOVT","form_type":"8-K","filed_at":"2023-03-01T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Novanta reports Q4 and FY2022 results; details not in filing text","summary_kind":"llm","event_type":"earnings","confidence":"low","bullets":["Novanta announced Q4 and full year 2022 financial results on March 1, 2023.","No revenue, EPS, or segment figures are available in the 8-K filing text.","The press release (Exhibit 99.1) is referenced but not appended to this summary.","Investors should obtain the full press release for specific numbers."],"consensus_eps_estimate":null,"consensus_eps_actual":2.06,"consensus_revenue_estimate":null,"consensus_revenue_actual":860903000.0,"consensus_period":"2022-FY","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":5751671008.7092905,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":330678,"accession_number":"0000950170-22-022917","cik":1076930,"company_name":"NOVANTA INC","ticker":"NOVT","form_type":"8-K","filed_at":"2022-11-08T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Novanta Q3 revenue up 26% to $223M; raises FY2022 guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["GAAP revenue $223M, +26% YoY; diluted EPS $0.63, +66% YoY.","Adjusted EPS $0.81 (+8% YoY); Adjusted EBITDA $49.4M.","GAAP net income $22.5M vs $13.6M in prior-year quarter.","Full-year 2022 guidance raised; no specific figures in release."],"consensus_eps_estimate":null,"consensus_eps_actual":1.64,"consensus_revenue_estimate":null,"consensus_revenue_actual":642530000.0,"consensus_period":"2022-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":5751671008.7092905,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":348179,"accession_number":"0001564590-22-028593","cik":1076930,"company_name":"NOVANTA INC","ticker":"NOVT","form_type":"8-K","filed_at":"2022-08-09T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Novanta Q2 2022: revenue up 29% to $215M; EPS $0.49; raises full-year guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["GAAP revenue $215.4M (+29% YoY); operating income $23.3M.","GAAP diluted EPS $0.49 (+48% YoY); adjusted diluted EPS $0.78 (+26%).","Adjusted EBITDA $45.0M vs. $37.0M in prior-year quarter.","Company raised full-year 2022 guidance (specific numeric guidance not provided in release)."],"consensus_eps_estimate":null,"consensus_eps_actual":1.01,"consensus_revenue_estimate":null,"consensus_revenue_actual":419572000.0,"consensus_period":"2022-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":5751671008.7092905,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":348178,"accession_number":"0001564590-22-026481","cik":1076930,"company_name":"NOVANTA INC","ticker":"NOVT","form_type":"8-K","filed_at":"2022-07-26T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Director Ira Lamel resigns; Barbara Hulit elected to Novanta board","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Ira J. Lamel resigned as director of Novanta effective July 26, 2022.","Barbara B. Hulit elected to fill the vacancy, effective July 26, 2022; will serve on ESG Committee.","Hulit receives standard director compensation: $62,500 cash retainer and $125,000 equity award, prorated for 2022."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":5751671008.7092905,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":348177,"accession_number":"0001564590-22-025567","cik":1076930,"company_name":"NOVANTA INC","ticker":"NOVT","form_type":"8-K","filed_at":"2022-07-11T23:59:59+00:00","items":["7.01"],"status":"ready","headline":"Novanta names Michele D. Welsh as General Counsel and Corporate Secretary","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Appointment effective July 11, 2022; Welsh will lead global legal, regulatory, corporate secretary, and EHS teams.","Welsh brings over 20 years of legal experience at public companies, most recently as VP, Assistant GC at Carlisle Companies (CSL).","Previously held senior legal roles at Aon plc (AON) from 2007 to 2018.","Practiced law at Thompson Coburn LLP and Neal, Gerber and Eisenberg LLP; holds JD from Boston College Law School."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":5751671008.7092905,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":364860,"accession_number":"0001564590-22-024521","cik":1076930,"company_name":"NOVANTA INC","ticker":"NOVT","form_type":"8-K","filed_at":"2022-06-28T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Novanta director Brian King resigns; Dr. Darlene Solomon appointed to board","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Brian King resigned as director effective June 28, 2022.","Dr. Darlene J.S. Solomon elected to board effective June 28, 2022, filling a vacancy.","Dr. Solomon will serve on the Compensation Committee.","She receives standard non-employee director compensation: $62,500 cash retainer plus $125,000 annual equity (50% RSUs, 50% DSUs), prorated for 2022."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":5751671008.7092905,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":364859,"accession_number":"0001564590-22-020415","cik":1076930,"company_name":"NOVANTA INC","ticker":"NOVT","form_type":"8-K","filed_at":"2022-05-16T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Novanta shareholders elect all 8 directors, approve say-on-pay and auditor at AGM","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["All eight director nominees elected; Thomas Secor received the most withhold votes (2,088,251).","Advisory say-on-pay approved with 31,057,232 votes for, 939,214 against, 24,520 abstained.","PricewaterhouseCoopers LLP ratified as auditor for 2023 with 32,624,275 for, 154,408 against.","Total shares present represented 91.91% of outstanding common shares as of March 31, 2022."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":5751671008.7092905,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":364858,"accession_number":"0001564590-22-019081","cik":1076930,"company_name":"NOVANTA INC","ticker":"NOVT","form_type":"8-K","filed_at":"2022-05-10T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Novanta Q1 2022 revenue up 26% to $204M; adjusted EPS $0.73","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["GAAP revenue $204.2M, up 26% YoY from $162.6M; GAAP net income $18.8M.","GAAP diluted EPS $0.53; adjusted diluted EPS $0.73, up 26% YoY.","Adjusted EBITDA $43.6M, +33% YoY from $32.7M.","No forward guidance was provided in the release."],"consensus_eps_estimate":null,"consensus_eps_actual":0.53,"consensus_revenue_estimate":null,"consensus_revenue_actual":204216000.0,"consensus_period":"2022-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":5751671008.7092905,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":384472,"accession_number":"0001564590-22-010412","cik":1076930,"company_name":"NOVANTA INC","ticker":"NOVT","form_type":"8-K","filed_at":"2022-03-15T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"Novanta extends credit facility maturity to 2027, increases accordion to $350M, adopts SOFR","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Maturity date extended from Dec 31, 2024 to March 10, 2027.","Uncommitted accordion option increased from $200M to $350M.","LIBOR replaced with SOFR as the reference rate for USD borrowings.","Novanta Inc. added as a borrower under the credit agreement.","Pricing grid updated per the Fifth Amendment."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":5751671008.7092905,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":384471,"accession_number":"0001564590-22-007870","cik":1076930,"company_name":"NOVANTA INC","ticker":"NOVT","form_type":"8-K","filed_at":"2022-03-01T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Novanta FY2021 revenue $707M (+20% YoY), adjusted EPS $2.62 (+34% YoY)","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Full year 2021 GAAP revenue of $706.8M, up 20% from $590.6M in 2020.","Full year 2021 GAAP diluted EPS $1.41 vs $1.25; adjusted diluted EPS $2.62 vs $1.95.","Full year 2021 adjusted EBITDA $152.7M, up from $121.0M in 2020.","Q4 2021 revenue $199.0M, adjusted diluted EPS $0.67.","Net income for full year 2021 was $50.3M, up from $44.5M in 2020."],"consensus_eps_estimate":null,"consensus_eps_actual":1.41,"consensus_revenue_estimate":null,"consensus_revenue_actual":706793000.0,"consensus_period":"2021-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":5751671008.7092905,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":402324,"accession_number":"0001564590-21-056708","cik":1076930,"company_name":"NOVANTA INC","ticker":"NOVT","form_type":"8-K","filed_at":"2021-11-12T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Director Deborah DiSanzo resigns from Novanta board effective Feb 28, 2022","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Deborah DiSanzo resigns from Board to focus on her role as President of Best Buy Health.","Resignation effective February 28, 2022; no replacement announced.","DiSanzo was not a named executive officer; resignation is for professional commitments."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":5751671008.7092905,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":402323,"accession_number":"0001564590-21-055458","cik":1076930,"company_name":"NOVANTA INC","ticker":"NOVT","form_type":"8-K","filed_at":"2021-11-09T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Novanta Q3 revenue $177.7M (+24% YoY); adj. EPS $0.75, raises FY guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["GAAP revenue $177.7M, up 24% from $142.9M in Q3 2020.","GAAP net income $13.6M ($0.38 diluted EPS) vs $8.3M ($0.23) YoY.","Adjusted diluted EPS $0.75 vs $0.42 YoY; adjusted EBITDA $40.4M vs $30.2M.","Company raised full-year 2021 guidance (specific figures not disclosed in excerpt)."],"consensus_eps_estimate":null,"consensus_eps_actual":1.02,"consensus_revenue_estimate":null,"consensus_revenue_actual":507833000.0,"consensus_period":"2021-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":5751671008.7092905,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":"2021-11-09T23:59:59+00:00|402323"}